Effect on Survival of Estrogen Replacement Therapy After Coronary Artery Bypass Grafting

Abstract We examined the relation between postmenopausal estrogen placement therapy (ERT) and survival in 1,098 women who underwent coronary artery bypass grafting (CABG). Patients were selected for the study if their age was ≥55 years at the time of preoperative coronary angiography or if they had previously undergone bilateral oophorectomy. Life-table analysis was used to compare survival after surgery in 92 women who received ERT and 1,006 women who did not. Five-year survival was 98.8% in the estrogen users and 82.3% in the nonusers. Ten-year survival was 81.4% in the users and 65.1% in the nonusers (p = 0.0001 by Lee Desu test). The women who did not take estrogen were significantly older (p The relationship between postmenopausal estrogen use and survival was examined in 1,098 women who underwent coronary artery bypass surgery. A Cox proportional-hazards model selected the number of vessels diseased, estrogen use, left main coronary stenosis, and diabetes mellitus as the significant independent predictors of survival.